Company Profile

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.

Latest News

Wedbush Raises Price Target on Climb Bio to $20 From $17, Keeps Outperform Rating

MT Newswires • 07/27/2026

Citigroup Downgrades Albertsons to Neutral From Buy, Lowers Price Target to $11 From $17

MT Newswires • 07/27/2026

OpenAI to triple workforce at Dublin European headquarters to 350

Reuters • 07/27/2026

Medaro Mining Completes Airborne Geophysical Survey, Phase 1 Exploration Program

MT Newswires • 07/27/2026

AMC, IMAX Report Strong 'Odyssey' Ticket Sales in Second Weekend

MT Newswires • 07/27/2026